Delisting Determination,The Nasdaq Stock Market, LLC,
August 20, 2013, PURE Bioscience, Inc.
The Nasdaq Stock Market, Inc. (the Exchange) has determined
to remove from listing the common stock of PURE Bioscience, Inc.
(the Company), effective at the opening of the trading
session on August 30, 2013. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(1).
The Company was notified of the Staffs
determination on March 4, 2013.  The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated April 24, 2013, granting
the Company continued listing pursuant to an exception
through June 18, 2013, by which date the Company was
required to regain compliance with Listing Rule 5550(b)(1).
However, the Company did not regain compliance
by that date. On May 15, 2013,
the Panel issued a final delisting determination and
notified the Company that trading in the Companys
securities would be suspended on May 17, 2013.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on July 1, 2013.